Nautilus Biotechnology, Inc.

Nasdaq:NAUT

Laboratory Analytical Instruments·SEATTLE, WA

A nautilus is any of the various species within the cephalopod family Nautilidae. This is the sole extant family of the infraorder Nautilaceae and the suborder Nautilina.

CEO

Patel Sujal M

CFO

Mowry Anna

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/26/26	→
10-Q	Q3 2025	9/30/25	10/28/25	→
10-Q	Q2 2025	6/30/25	7/31/25	→
10-Q	Q1 2025	3/31/25	4/29/25	→
10-K	FY 2024	12/31/24	2/27/25	→
10-Q	Q3 2024	9/30/24	10/29/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
2/26/26	Q1 FY2026	→
10/28/25	Q3 FY2025	→
7/31/25	Q2 FY2025	→
4/29/25	Q1 FY2025	→
2/27/25	Q1 FY2025	→
10/29/24	Q3 FY2024	→
↓

News (8-K)

19 shown

Filed	Type	Description
11/4/25	Other	Other Events	→
6/23/25	Vote	Submission of Matters to a Vote of Security Holders	→
5/2/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
1/31/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/13/24	Vote	Submission of Matters to a Vote of Security Holders	→
2/28/24	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

32 shown

Filed	Form	Description
2/26/26	S-8	S-8	→
4/29/25	ARS	ARS	→
2/27/25	S-8	S-8	→
4/26/24	ARS	ARS	→
3/6/24	424B5	424B5	→
2/28/24	S-3	S-3	→
↓

Filing History(302 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13D/A

Mar 4, 2026

0001378830-26-000005

—

9.7 KB

SCHEDULE 13D/A

Mar 4, 2026

0001857948-26-000003

—

9.3 KB

Mar 4, 2026

0001378830-26-000003FORM 4

Mar 4, 2026

6.8 KB

Mar 4, 2026

0001856938-26-000001FORM 4

Mar 2, 2026

5.8 KB

Mar 4, 2026

0001857948-26-000001FORM 4

Mar 2, 2026

5.8 KB

Mar 4, 2026

0001378830-26-000001FORM 4

Mar 2, 2026

5.8 KB

Mar 4, 2026

0001856744-26-000001FORM 4

Mar 2, 2026

5.8 KB

Mar 4, 2026

0001378831-26-000001FORM 4

Mar 2, 2026

5.8 KB

Mar 4, 2026

0001865778-26-000001FORM 4

Mar 2, 2026

5.8 KB

Mar 4, 2026

0002037191-26-000001FORM 4

Mar 2, 2026

5.8 KB

S-8

Feb 26, 2026

0001808805-26-000013S-8

—

344.5 KB

10-K

Feb 26, 2026

0001808805-26-00001110-K

Dec 31, 2025

22.8 MB

8-K

Feb 26, 2026

0001808805-26-0000048-K

Feb 26, 2026

250.3 KB

Nov 10, 2025

0002037191-25-000004FORM 4

Nov 6, 2025

4.5 KB

8-K

Nov 4, 2025

0001808805-25-0000828-K

Nov 3, 2025

139.8 KB

10-Q

Oct 28, 2025

0001808805-25-00008010-Q

Sep 30, 2025

5.4 MB

8-K

Oct 28, 2025

0001808805-25-0000778-K

Oct 28, 2025

249.2 KB

Sep 9, 2025

0001378830-25-000003FORM 4

Sep 5, 2025

8.6 KB

Sep 5, 2025

0001865778-25-000003FORM 4

Sep 4, 2025

5.4 KB

10-Q

Jul 31, 2025

0001808805-25-00007210-Q

Jun 30, 2025

5.2 MB

8-K

Jul 31, 2025

0001808805-25-0000698-K

Jul 31, 2025

248.0 KB

Jun 25, 2025

0001808805-25-000064FORM 4

Jun 23, 2025

5.6 KB

Jun 25, 2025

0001808805-25-000063FORM 4

Jun 23, 2025

5.5 KB

Jun 25, 2025

0001808805-25-000062FORM 4

Jun 23, 2025

5.5 KB

Jun 25, 2025

0001808805-25-000061FORM 4

Jun 23, 2025

5.5 KB

25 filings shown

Nautilus Biotechnology, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(302 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/29/25	DEFA14A	DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/27/23	DEFA14A	DEFA14A	→
4/27/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
3/4/26	4	4	→
3/4/26	4	4	→
3/4/26	4	4	→
3/4/26	4	4	→
3/4/26	4	4	→
3/4/26	4	4	→
↓